Worse PFS Seen with Nivolumab-Rucaparib in Ovarian Cancer
The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.
Medscape Medical News
source https://www.medscape.com/viewarticle/nivolumab-rucaparib-not-superior-rucaparib-maintenance-tx-2024a1000gq5?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/nivolumab-rucaparib-not-superior-rucaparib-maintenance-tx-2024a1000gq5?src=rss
Comments
Post a Comment